Avail is conducting randomized, placebo-controlled clinical studies to assess the efficacy and long-term safety of new therapies for renal impairment, chronic kidney disease and diabetic nephropathy. Those who are interested can visit their website or call their clinic to learn more about participating in one their clinical trials.